Details for New Drug Application (NDA): 204735
✉ Email this page to a colleague
The generic ingredient in CABERGOLINE is cabergoline. There are twelve drug master file entries for this compound. Nine suppliers are listed for this compound. Additional details are available on the cabergoline profile page.
Summary for 204735
Tradename: | CABERGOLINE |
Applicant: | Ingenus Pharms Llc |
Ingredient: | cabergoline |
Patents: | 0 |
Suppliers and Packaging for NDA: 204735
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
CABERGOLINE | cabergoline | TABLET;ORAL | 204735 | ANDA | A-S Medication Solutions | 50090-5834 | 50090-5834-0 | 8 TABLET in 1 BOTTLE (50090-5834-0) |
CABERGOLINE | cabergoline | TABLET;ORAL | 204735 | ANDA | Ingenus Pharmaceuticals, LLC | 50742-118 | 50742-118-08 | 8 TABLET in 1 BOTTLE (50742-118-08) |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 0.5MG | ||||
Approval Date: | Aug 1, 2018 | TE: | AB | RLD: | No |
Complete Access Available with Subscription